03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Eric Crombez: no photograph is held, so the academic plate is shown instead.
Academic
Eric Crombez
M.D., chief medical officer of Ultragenyx
Aug 2026Sept 2026Oct 2026Nov 2026to date
1
Quoted in the press, across 1 topic since 20 Aug 2026
02 Quoted on · 1 of 29 topics
Eric Crombez: key facts
- Kind of voice
- Academic
- Role
- M.D., chief medical officer of Ultragenyx
- Quoted on
- Rare diseases
- Press coverage
- Quoted in the press
- Most recently quoted
- 20 Aug 2026
04 On the record · press
What Eric Crombez has said
By outlet · bar length shows relative volume
- fiercepharma.com
Where Eric Crombez has been quoted
- Ultragenyx, after FDA speed bump, lands 1st gene therapy nod with green light in glycogen storage diseasefiercepharma.com · 20 Aug 2026
How we found the articles that name Eric Crombez: we searched news for these terms.
- rare disease
- rare conditions
- orphan drugs
- genetic disorder
- cystic fibrosis
- motor neurone disease
- muscular dystrophy
- Huntington
Also searched with “rare disease” in each of 8 national papers. Every term for Rare diseases
Verbatim
“The reduced reliance on cornstarch, experienced by patients in our clinical studies, demonstrates this gene therapy's ability to establish the normal breakdown of glycogen to produce glucose during fasting or episodes of metabolic stress. This ability to regulate glucose has alleviated the disease burden and has the potential to mitigate the risk of severe or life-threatening hypoglycemia for these patients.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.